-
1
-
-
10844292763
-
Immunosuppressive drugs for kidney transplantation
-
doi:10.1056/NEJMra033540
-
Halloran PF. Immunosuppressive drugs for kidney transplantation. N Engl J Med 2004;351:2715-2729. doi:10.1056/NEJMra033540
-
(2004)
N Engl J Med
, vol.351
, pp. 2715-2729
-
-
Halloran, P.F.1
-
2
-
-
34247238869
-
Kidney and pancreas transplantation in the United States, 1996-2005
-
Andreoni KA, Brayman KL, Guidinger MK, Sommers CM, Sung RS. Kidney and pancreas transplantation in the United States, 1996-2005. Am J Transplant 2007;7:1359-1375.
-
(2007)
Am J Transplant
, vol.7
, pp. 1359-1375
-
-
Andreoni, K.A.1
Brayman, K.L.2
Guidinger, M.K.3
Sommers, C.M.4
Sung, R.S.5
-
3
-
-
0008922584
-
-
Mycophenolate, Greenwood Village, CO: Thomson Micromedex. Expires December 31, 2013, accessed 2012 Mar 11
-
Mycophenolate. Drugdex system. Greenwood Village, CO: Thomson Micromedex. Expires December 31, 2013. http://www.thomsonhc.com/micromedex2/librarian/ND_T/evidencexpert/ND_PR/evidencexpert/CS/BABCA2/ND_AppProduct/evidencexpert/DUPLICATIONSHIELDSYNC/668B34/ND_PG/evidencexpert/ND_B/evidencexpert/ND_P/evidencexpert/PFActionId/evidencexpert.IntermediateToDocumentLink?docId=0461&contentSetId=31&title=MYCOPHENOLIC+ACID&servicesTitle=MYCOPHENOLIC+ACID&topicId=null (accessed 2012 Mar 11).
-
Drugdex System
-
-
-
4
-
-
33846230492
-
Clinical pharmacokinetics and pharmacodynamics ofmycophenolate in solid organ transplant recipients
-
Staatz CE, Tett SE. Clinical pharmacokinetics and pharmacodynamics ofmycophenolate in solid organ transplant recipients. Clin Pharmacokinet 2007;46:13-58.
-
(2007)
Clin Pharmacokinet
, vol.46
, pp. 13-58
-
-
Staatz, C.E.1
Tett, S.E.2
-
5
-
-
80051785897
-
Gastrointestinal quality of life improvement of renal transplant recipients converted from mycophenolate mofetil to enteric-coated mycophenolate sodium drugs or agents: Mycophenolate mofetil and enteric-coated mycophenolate sodium
-
doi:10.1097/TP.0b013e31822527ca
-
Ortega F, Sanchez-Fructuoso A, Cruzado JM, et al. Gastrointestinal quality of life improvement of renal transplant recipients converted from mycophenolate mofetil to enteric-coated mycophenolate sodium drugs or agents: mycophenolate mofetil and enteric-coated mycophenolate sodium. Transplantation 2011;92:426-432. doi:10.1097/TP.0b013e31822527ca
-
(2011)
Transplantation
, vol.92
, pp. 426-432
-
-
Ortega, F.1
Sanchez-Fructuoso, A.2
Cruzado, J.M.3
-
6
-
-
79959436407
-
Reduction of gastrointestinal complications in renal graft recipients after conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium
-
doi:10.1016/j.transproceed.2011.01.184
-
Reinke P, Budde K, Hugo C, et al. Reduction of gastrointestinal complications in renal graft recipients after conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium. Transplant Proc 2011;43:1641-1646. doi:10.1016/j.transproceed.2011.01.184
-
(2011)
Transplant Proc
, vol.43
, pp. 1641-1646
-
-
Reinke, P.1
Budde, K.2
Hugo, C.3
-
7
-
-
81855169543
-
Emergency hospitalizations for adverse drug events in older Americans
-
doi:10.1056/NEJMsa1103053
-
Budnitz DS, Lovegrove MC, Shehab N, Richards CL. Emergency hospitalizations for adverse drug events in older Americans. N Engl J Med 2011;365:2002-2012. doi:10.1056/NEJMsa1103053
-
(2011)
N Engl J Med
, vol.365
, pp. 2002-2012
-
-
Budnitz, D.S.1
Lovegrove, M.C.2
Shehab, N.3
Richards, C.L.4
-
8
-
-
69549088254
-
Drug interactions in transplant patients: What everyone should know
-
doi:10.1097/MNH.0b013e32832edcb2
-
Manitpisitkul W, McCann E, Lee S, Weir MR. Drug interactions in transplant patients: what everyone should know. Curr Opin Nephrol Hypertens 2009;18:404-411. doi:10.1097/MNH.0b013e32832edcb2
-
(2009)
Curr Opin Nephrol Hypertens
, vol.18
, pp. 404-411
-
-
Manitpisitkul, W.1
McCann, E.2
Lee, S.3
Weir, M.R.4
-
9
-
-
14744293831
-
Drug dosing in chronic kidney disease
-
S0025-7125. doi:10.1016/j.mcna.2004.11.007
-
Gabardi S, Abramson S. Drug dosing in chronic kidney disease. Med Clin North Am 2005;89:649-687. S0025-7125. doi:10.1016/j.mcna.2004.11.007
-
(2005)
Med Clin North Am
, vol.89
, pp. 649-687
-
-
Gabardi, S.1
Abramson, S.2
-
10
-
-
69949163535
-
Immunotherapy in elderly transplant recipients: A guide to clinically significant drug interactions
-
doi:10.2165/11316480-000000000-00000
-
Kuypers DR. Immunotherapy in elderly transplant recipients: a guide to clinically significant drug interactions. Drugs Aging 2009;26:715-737. doi:10.2165/11316480-000000000-00000
-
(2009)
Drugs Aging
, vol.26
, pp. 715-737
-
-
Kuypers, D.R.1
-
11
-
-
0142244563
-
Enteric-coated mycophenolate sodium
-
doi:10.1345/aph.1D063
-
Gabardi S, Tran JL, Clarkson MR. Enteric-coated mycophenolate sodium. Ann Pharmacother 2003;37:1685-1693. doi:10.1345/aph.1D063
-
(2003)
Ann Pharmacother
, vol.37
, pp. 1685-1693
-
-
Gabardi, S.1
Tran, J.L.2
Clarkson, M.R.3
-
12
-
-
0346996613
-
Mycophenolate mofetil in solid-organ transplantation
-
doi:10.1517/14656566.4.12.2325
-
Srinivas TR, Kaplan B, Meier-Kriesche HU. Mycophenolate mofetil in solid-organ transplantation. Expert Opin Pharmacother 2003;4:2325-2345. doi:10.1517/14656566.4.12.2325
-
(2003)
Expert Opin Pharmacother
, vol.4
, pp. 2325-2345
-
-
Srinivas, T.R.1
Kaplan, B.2
Meier-Kriesche, H.U.3
-
13
-
-
0034981409
-
Prophylaxis and treatment of gastrointestinal complications following transplantation
-
Helderman JH. Prophylaxis and treatment of gastrointestinal complications following transplantation. Clin Transplant 2001;15(suppl 4):29-35.
-
(2001)
Clin Transplant
, vol.15
, Issue.SUPPL. 4
, pp. 29-35
-
-
Helderman, J.H.1
-
14
-
-
0034991912
-
Gastrointestinal infectious disease complications following transplantation and their differentiation from immunosuppressant-induced gastrointestinal toxicities
-
Rubin RH. Gastrointestinal infectious disease complications following transplantation and their differentiation from immunosuppressant-induced gastrointestinal toxicities. Clin Transplant 2001;15(suppl 4):11-22.
-
(2001)
Clin Transplant
, vol.15
, Issue.SUPPL. 4
, pp. 11-22
-
-
Rubin, R.H.1
-
15
-
-
0034889041
-
Adverse gastrointestinal effects of mycophenolate mofetil: Aetiology, incidence and management
-
Behrend M. Adverse gastrointestinal effects of mycophenolate mofetil: aetiology, incidence and management. Drug Saf 2001;24:645-663.
-
(2001)
Drug Saf
, vol.24
, pp. 645-663
-
-
Behrend, M.1
-
16
-
-
77958035150
-
Enteric-coated mycophenolate sodium
-
doi:10.1517/14740338.2010.513379
-
Budde K, Durr M, Liefeldt L, Neumayer HH, Glander P. Enteric-coated mycophenolate sodium. Expert Opin Drug Saf 2010;9:981-994. doi:10.1517/14740338.2010.513379
-
(2010)
Expert Opin Drug Saf
, vol.9
, pp. 981-994
-
-
Budde, K.1
Durr, M.2
Liefeldt, L.3
Neumayer, H.H.4
Glander, P.5
-
17
-
-
71249141502
-
Mycophenolate mofetil: An update
-
doi:10.1358/dot.2009.45.7.1384878
-
Villarroel MC, Hidalgo M, Jimeno A. Mycophenolate mofetil: an update. Drugs Today (Barc) 2009;45:521-532. doi:10.1358/dot.2009.45.7.1384878
-
(2009)
Drugs Today (Barc)
, vol.45
, pp. 521-532
-
-
Villarroel, M.C.1
Hidalgo, M.2
Jimeno, A.3
-
18
-
-
0042536429
-
Mycophenolate mofetil dose reduction and the risk of acute rejection after renal transplantation
-
Knoll GA, MacDonald I, Khan A, van Walraven C. Mycophenolate mofetil dose reduction and the risk of acute rejection after renal transplantation. J Am Soc Nephrol 2003;14:2381-2386.
-
(2003)
J Am Soc Nephrol
, vol.14
, pp. 2381-2386
-
-
Knoll, G.A.1
Macdonald, I.2
Khan, A.3
van Walraven, C.4
-
19
-
-
0027218826
-
Immunosuppressive activity of mycophenolate mofetil
-
Eugui EM, Allison AC. Immunosuppressive activity of mycophenolate mofetil. Ann N Y Acad Sci 1993;685:309-329.
-
(1993)
Ann N Y Acad Sci
, vol.685
, pp. 309-329
-
-
Eugui, E.M.1
Allison, A.C.2
-
20
-
-
0034045586
-
Mycophenolate mofetil and its mechanisms of action
-
Allison AC, Eugui EM. Mycophenolate mofetil and its mechanisms of action. Immunopharmacology 2000;47:85-118.
-
(2000)
Immunopharmacology
, vol.47
, pp. 85-118
-
-
Allison, A.C.1
Eugui, E.M.2
-
21
-
-
0029918886
-
Purine metabolism and immunosuppressive effects of mycophenolate mofetil (MMF)
-
Allison AC, Eugui EM. Purine metabolism and immunosuppressive effects of mycophenolate mofetil (MMF). Clin Transplant 1996;10:77-84.
-
(1996)
Clin Transplant
, vol.10
, pp. 77-84
-
-
Allison, A.C.1
Eugui, E.M.2
-
22
-
-
0027762592
-
Human type I and II IMP dehydrogenases as drug targets
-
Natsumeda Y, Carr SF. Human type I and II IMP dehydrogenases as drug targets. Ann N Y Acad Sci 1993;696:88-93.
-
(1993)
Ann N Y Acad Sci
, vol.696
, pp. 88-93
-
-
Natsumeda, Y.1
Carr, S.F.2
-
23
-
-
34548795914
-
Gastrointestinal complications in renal transplant recipients: MITOS study
-
doi:10.1016/j.transproceed.2007.07.015
-
Gil-Vernet S, Amado A, Ortega F, et al. Gastrointestinal complications in renal transplant recipients: MITOS study. Transplant Proc 2007;39:2190-193. doi:10.1016/j.transproceed.2007.07.015
-
(2007)
Transplant Proc
, vol.39
, pp. 2190-2193
-
-
Gil-Vernet, S.1
Amado, A.2
Ortega, F.3
-
24
-
-
84872605492
-
-
Presented at: European Symposium on Clinical Pharmacy; Amsterdam, Netherlands; October 27, 2005
-
Lalla AM, Gabardi S, Gilmore AS, Machnicki G, Legorreta AP. Use of gastrointestinal medications following renal transplantation. Presented at: European Symposium on Clinical Pharmacy; Amsterdam, Netherlands; October 27, 2005.
-
Use of Gastrointestinal Medications Following Renal Transplantation
-
-
Lalla, A.M.1
Gabardi, S.2
Gilmore, A.S.3
Machnicki, G.4
Legorreta, A.P.5
-
25
-
-
12144273473
-
Long-term outcome of gastrointestinal complications in renal transplant patients treated with mycophenolate mofetil
-
doi:10.1007/s00147-004-0768-6
-
Hardinger KL, Brennan DC, Lowell J, Schnitzler MA. Long-term outcome of gastrointestinal complications in renal transplant patients treated with mycophenolate mofetil. Transpl Int 2004;17:609-616. doi:10.1007/s00147-004-0768-6
-
(2004)
Transpl Int
, vol.17
, pp. 609-616
-
-
Hardinger, K.L.1
Brennan, D.C.2
Lowell, J.3
Schnitzler, M.A.4
-
26
-
-
40049085792
-
Increased risk of graft failure in kidney transplant recipients after a diagnosis of dyspepsia or gastroesophageal reflux disease
-
doi:10.1097/TP.0b013e318160d4c4
-
Neri L, Rocca Rey LA, Pinsky BW, et al. Increased risk of graft failure in kidney transplant recipients after a diagnosis of dyspepsia or gastroesophageal reflux disease. Transplantation 2008;85:344-352. doi:10.1097/TP.0b013e318160d4c4
-
(2008)
Transplantation
, vol.85
, pp. 344-352
-
-
Neri, L.1
Rocca, R.L.A.2
Pinsky, B.W.3
-
27
-
-
33747494883
-
Mycophenolate mofetil dose reductions and discontinuations after gastrointestinal complications are associated with renal transplant graft failure
-
doi:10.97/01.tp.0000225760.09969
-
Bunnapradist S, Lentine KL, Burroughs TE, et al. Mycophenolate mofetil dose reductions and discontinuations after gastrointestinal complications are associated with renal transplant graft failure. Transplantation 2006;82:102-107. doi:10.97/01.tp.0000225760.09969
-
(2006)
Transplantation
, vol.82
, pp. 102-107
-
-
Bunnapradist, S.1
Lentine, K.L.2
Burroughs, T.E.3
-
29
-
-
38549136645
-
Influence of lansoprazole and rabeprazole on mycophenolic acid pharmacokinetics one year after renal transplantation
-
doi:10.1097/FTD.0b013e31816337b7
-
Miura M, Satoh S, Inoue K, et al. Influence of lansoprazole and rabeprazole on mycophenolic acid pharmacokinetics one year after renal transplantation. Ther Drug Monit 2008;30:46-51. doi:10.1097/FTD.0b013e31816337b7
-
(2008)
Ther Drug Monit
, vol.30
, pp. 46-51
-
-
Miura, M.1
Satoh, S.2
Inoue, K.3
-
30
-
-
65749114832
-
Proton pump inhibitor co-medication reduces mycophenolate acid drug exposure in heart transplant recipients
-
doi:10.16/j.healun.2009.03.006
-
Kofler S, Deutsch MA, Bigdeli AK, et al. Proton pump inhibitor co-medication reduces mycophenolate acid drug exposure in heart transplant recipients. J Heart Lung Transplant 2009;28:605-611. doi:10.16/j.healun.2009.03.006
-
(2009)
J Heart Lung Transplant
, vol.28
, pp. 605-611
-
-
Kofler, S.1
Deutsch, M.A.2
Bigdeli, A.K.3
-
31
-
-
67649655600
-
Proton pump inhibitors reduce mycophenolate exposure in heart transplant recipients-a prospective casecontrolled study
-
doi:10.1111/j.1600-6143.2009.02682.x
-
Kofler S, Shvets N, Bigdeli AK, et al. Proton pump inhibitors reduce mycophenolate exposure in heart transplant recipients-a prospective casecontrolled study. Am J Transplant 2009;9:1650-1656. doi:10.1111/j.1600-6143.2009.02682.x
-
(2009)
Am J Transplant
, vol.9
, pp. 1650-1656
-
-
Kofler, S.1
Shvets, N.2
Bigdeli, A.K.3
-
32
-
-
78650470433
-
Proton pump inhibitor comedication reduces active drug exposure in heart transplant recipients receiving mycophenolate mofetil
-
S0041-1345. doi:10.16/j.transproceed.2010.09.047
-
Doesch AO, Mueller S, Konstandin M, et al. Proton pump inhibitor comedication reduces active drug exposure in heart transplant recipients receiving mycophenolate mofetil. Transplant Proc 2010;42:4243-4246. S0041-1345. doi:10.16/j.transproceed.2010.09.047
-
(2010)
Transplant Proc
, vol.42
, pp. 4243-4246
-
-
Doesch, A.O.1
Mueller, S.2
Konstandin, M.3
-
33
-
-
78649355482
-
Proton pump inhibitors interfere with the immunosuppressive potency of mycophenolate mofetil
-
doi:10.1093/rheumatology/keq238
-
Schaier M, Scholl C, Scharpf D, et al. Proton pump inhibitors interfere with the immunosuppressive potency of mycophenolate mofetil. Rheumatology (Oxford) 2010;49:2061-2067. doi:10.1093/rheumatology/keq238
-
(2010)
Rheumatology (Oxford)
, vol.49
, pp. 2061-2067
-
-
Schaier, M.1
Scholl, C.2
Scharpf, D.3
-
34
-
-
70349479420
-
Bioavailability of mycophenolate mofetil and enteric-coated mycophenolate sodium is differentially affected by pantoprazole in healthy volunteers
-
doi:10.1177/0091270009344988
-
Rupprecht K, Schmidt C, Raspe A, et al. Bioavailability of mycophenolate mofetil and enteric-coated mycophenolate sodium is differentially affected by pantoprazole in healthy volunteers. J Clin Pharmacol 2009;49:1196-1201. doi:10.1177/0091270009344988
-
(2009)
J Clin Pharmacol
, vol.49
, pp. 1196-1201
-
-
Rupprecht, K.1
Schmidt, C.2
Raspe, A.3
-
35
-
-
84864397182
-
Omeprazole impairs the absorption of mycophenolate mofetil but not of enteric-coated mycophenolate sodium in healthy volunteers
-
8 Sept 2011, doi:10.1177/0091270011412968
-
Kees MG, Steinke T, Moritz S, et al. Omeprazole impairs the absorption of mycophenolate mofetil but not of enteric-coated mycophenolate sodium in healthy volunteers. J Clin Pharmacol Epub 8 Sept 2011. doi:10.1177/0091270011412968
-
J Clin Pharmacol Epub
-
-
Kees, M.G.1
Steinke, T.2
Moritz, S.3
-
36
-
-
79953777778
-
The proton pump inhibitor pantoprazole and its interaction with enteric-coated mycophenolate sodium in transplant recipients
-
doi:10.1016/j.healun.2010.12.003
-
Kofler S, Wolf C, Shvets N, et al. The proton pump inhibitor pantoprazole and its interaction with enteric-coated mycophenolate sodium in transplant recipients. J Heart Lung Transplant 2011;30:565-571. doi:10.1016/j.healun.2010.12.003
-
(2011)
J Heart Lung Transplant
, vol.30
, pp. 565-571
-
-
Kofler, S.1
Wolf, C.2
Shvets, N.3
-
37
-
-
0037373072
-
Pharmacokinetics of mycophenolate mofetil in patients with autoimmune diseases compared renal transplant recipients
-
Neumann I, Haidinger M, Jager H, et al. Pharmacokinetics of mycophenolate mofetil in patients with autoimmune diseases compared renal transplant recipients. J Am Soc Nephrol 2003;14:721-727.
-
(2003)
J Am Soc Nephrol
, vol.14
, pp. 721-727
-
-
Neumann, I.1
Haidinger, M.2
Jager, H.3
-
38
-
-
77954764816
-
The CLEAR study: A 5-day, 3-g loading dose of mycophenolate mofetil versus standard 2-g dosing in renal transplantation
-
doi:10.2215/CJN.09091209
-
Gourishankar S, Houde I, Keown PA, et al. The CLEAR study: a 5-day, 3-g loading dose of mycophenolate mofetil versus standard 2-g dosing in renal transplantation. Clin J Am Soc Nephrol 2010;5:1282-1289. doi:10.2215/CJN.09091209
-
(2010)
Clin J Am Soc Nephrol
, vol.5
, pp. 1282-1289
-
-
Gourishankar, S.1
Houde, I.2
Keown, P.A.3
-
39
-
-
78751642276
-
The role of proton pump inhibitors on early mycophenolic acid exposure in kidney transplantation: Evidence from the CLEAR study
-
doi:10.1097/FTD.0b013e318206a1b1
-
Kiberd BA, Wrobel M, Dandavino R, Keown P, Gourishankar S. The role of proton pump inhibitors on early mycophenolic acid exposure in kidney transplantation: evidence from the CLEAR study. Ther Drug Monit 2011;33:120-123. doi:10.1097/FTD.0b013e318206a1b1
-
(2011)
Ther Drug Monit
, vol.33
, pp. 120-123
-
-
Kiberd, B.A.1
Wrobel, M.2
Dandavino, R.3
Keown, P.4
Gourishankar, S.5
-
40
-
-
13044305870
-
The pharmacokineticpharmacodynamic relationship for mycophenolate mofetil in renal transplantation
-
doi:10.1016/S0009-9236(98)90058-3
-
Hale MD, Nicholls AJ, Bullingham RE, et al. The pharmacokineticpharmacodynamic relationship for mycophenolate mofetil in renal transplantation. Clin Pharmacol Ther 1998;64:672-683. doi:10.1016/S0009-9236(98)90058-3
-
(1998)
Clin Pharmacol Ther
, vol.64
, pp. 672-683
-
-
Hale, M.D.1
Nicholls, A.J.2
Bullingham, R.E.3
-
41
-
-
77649116838
-
Mycophenolate mofetil versus enteric-coated mycophenolate sodium: A large, single-center comparison of dose adjustments and outcomes in kidney transplant recipients
-
doi:10.1097/TP.0b013e3181ca860d
-
Sollinger HW, Sundberg AK, Leverson G, Voss BJ, Pirsch JD. Mycophenolate mofetil versus enteric-coated mycophenolate sodium: a large, single-center comparison of dose adjustments and outcomes in kidney transplant recipients. Transplantation 2010;89:446-451. doi:10.1097/TP.0b013e3181ca860d
-
(2010)
Transplantation
, vol.89
, pp. 446-451
-
-
Sollinger, H.W.1
Sundberg, A.K.2
Leverson, G.3
Voss, B.J.4
Pirsch, J.D.5
-
42
-
-
28644442483
-
Impact of mycophenolate mofetil (MMF)-related gastrointestinal complications and MMF dose alterations on transplant outcomes and healthcare costs in renal transplant recipients
-
doi:10.1111/j.1399-0012.2005.00421.x
-
Tierce JC, Porterfield-Baxa J, Petrilla AA, Kilburg A, Ferguson RM. Impact of mycophenolate mofetil (MMF)-related gastrointestinal complications and MMF dose alterations on transplant outcomes and healthcare costs in renal transplant recipients. Clin Transplant 2005;19:779-784. doi:10.1111/j.1399-0012.2005.00421.x
-
(2005)
Clin Transplant
, vol.19
, pp. 779-784
-
-
Tierce, J.C.1
Porterfield-Baxa, J.2
Petrilla, A.A.3
Kilburg, A.4
Ferguson, R.M.5
-
43
-
-
79958229595
-
-
Hudson, OH.: Lexi-Comp, Inc
-
Lexicomp online. Hudson, OH.: Lexi-Comp, Inc., 2011.
-
(2011)
Lexicomp Online
-
-
-
45
-
-
84864741690
-
-
San Mateo, California, USA.: Epocrates, Inc
-
Epocrates Online. San Mateo, California, USA.: Epocrates, Inc., 2011.
-
(2011)
Epocrates Online
-
-
|